Hikari Power’s Acorda Therapeutics ACOR Stock Holding History

Hikari Power’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-297	Closed	-$703K	–	100
2017 Q2	$703K	Buy	297 +214	+258%	+$424K	0.09%	57
2017 Q1	$210K	Buy	+83	New	+$239K	0.03%	62

Other funds holding ACOR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Hikari Power's ACOR Position: Q3 2017 in Review

Hikari Power sold out of Acorda Therapeutics (ACOR) in Q3 2017, closing a stake of 297 shares — an estimated $703K sold.

Hikari Power first reported a position in ACOR in Q1 2017 and held it in 2 quarters. The position peaked at $703K in Q2 2017. 152 funds tracked by Wall St. Rank hold ACOR as of Q3 2017.

Hikari Power reported no remaining Acorda Therapeutics position as of Q3 2017 after selling out during the quarter.
Hikari Power sold 297 Acorda Therapeutics shares in Q3 2017, an estimated $703K.
Hikari Power first reported a position in Acorda Therapeutics in Q1 2017 and held it in 2 quarters.
Hikari Power's Acorda Therapeutics position peaked at $703K in Q2 2017.
152 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2017.

Based on Hikari Power's 13F filing for Q3 2017, filed 8 Nov 2017.